TABLE 3:

Laboratory Values Before and After Embolization of Hepatocellular Carcinoma Among Patients Taking and Not Taking Aspirin

	No Aspirin			Aspirin
Time After Initial Embolization (d)	Mean	SD	No.	Mean	SD	No.
Bilirubin (mg/dL)
Before	0.94	0.57	262	0.77	0.65	42
1	1.22	0.88	262	0.87	0.39	42
30	1.19	0.96	255	0.94	0.69	42
120	1.1	1.01	233	0.83	0.56	41
365	1.02	0.76	172	0.75	0.56	35
Albumin (g/dL)
Before	3.9	0.47	262	4.03	0.39	42
1	3.66	0.45	262	3.76	0.36	42
30	3.54	0.52	255	3.71	0.34	42
120	3.7	0.50	233	3.93	0.44	41
365	3.76	0.52	172	3.91	0.45	35
International normalized ratioa
Before	1.13	0.13	242	1.09	0.12	33
1	1.17	0.15	242	1.14	0.15	33
30	1.21	0.18	235	1.15	0.16	33
120	1.17	0.19	214	1.12	0.14	32
365	1.13	0.14	159	1.13	0.13	27
Aspartate transaminase (U/L)
Before	72	57	262	53	32	42
1	386	610	262	287	562	42
30	115	161	255	75	73	42
120	94	147	233	72	78	41
365	76	111	172	64	46	35
Alanine transaminase (U/L)
Before	62	49	262	50	31	42
1	254	423	262	192	336	42
30	112	161	255	82	77	42
120	79	119	233	66	68	41
365	61	71	172	59	41	35

Note—All patients had laboratory values before and 1 day after embolization.

^aIncludes only patients not undergoing anticoagulation.